GO:0016758 hexosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016758 hexosyltransferase activity describes the catalysis of transferring a hexosyl group from a donor to an acceptor molecule.
• This activity is central to glycogen synthesis, where UDP-glucose serves as the donor for glycogen synthase.
• Hexosyltransferases include enzymes such as glycogen synthase, UDP-glucuronyltransferases, and bacterial capsule polymerases [2, 6].
• Exercise and insulin signaling regulate glycogen synthase activity through phosphorylation and allosteric effectors [3, 4].
• Mutations in hexosyltransferase genes can cause metabolic disorders like McArdle disease and affect drug metabolism [2, 5].
• CRISPR-based models enable precise interrogation of hexosyltransferase function in health and disease.
Description
Hexosyltransferase activity (GO:0016758) is a fundamental molecular function that catalyzes the transfer of a hexosyl group from a donor compound to an acceptor molecule. This activity is essential for diverse biological processes, including glycogen biosynthesis, protein glycosylation, and the synthesis of bacterial capsular polysaccharides [4, 6]. Researchers study hexosyltransferases to understand metabolic regulation, drug conjugation, and host-pathogen interactions [2, 3]. The importance of this enzyme class is underscored by its involvement in human diseases such as glycogen storage disorders and its role in determining donor substrate specificity in pathogens [5, 6]. Understanding the molecular mechanisms and regulation of hexosyltransferases provides insights into cellular metabolism and offers potential therapeutic targets [4, 7].
hexosyltransferase activity At A Glance
| GO ID | GO:0016758 |
|---|---|
| GO term | hexosyltransferase activity |
| Ontology | molecular_function |
| Synonym | transferase activity, transferring hexosyl groups |
| Major function | Transfer of a hexosyl group from a donor to an acceptor molecule |
| Donor substrates | UDP-glucose, UDP-glucuronate, and other nucleotide sugars |
| Acceptor substrates | Proteins, lipids, carbohydrates, and small molecules |
| Representative enzymes | Glycogen synthase, UDP-glucuronyltransferases, capsule polymerases |
What Is GO:0016758?
Hexosyltransferase activity (GO:0016758) is defined as the catalysis of the transfer of a hexosyl group from one compound (donor) to another (acceptor). This activity is classified under molecular_function and includes enzymes that utilize nucleotide sugars, such as UDP-glucose or UDP-glucuronate, as donor substrates [2, 4]. The transfer reaction typically involves the formation of a glycosidic bond between the hexose and the acceptor molecule, which can be a protein, lipid, or another carbohydrate [6, 7].
Why Is hexosyltransferase activity Important in Cell Biology?
Hexosyltransferase activity is critical for numerous physiological processes, including energy storage, detoxification, and cell surface recognition [2, 4]. Dysregulation of these enzymes is linked to metabolic disorders, cancer, and infectious diseases, making them important targets for research and therapeutic development [5, 6].
• Essential for glycogen synthesis and energy homeostasis.
• Mediates phase II drug metabolism through glucuronidation.
• Determines bacterial capsule composition and virulence.
• Involved in protein glycosylation and cell signaling.
• Mutations cause glycogen storage diseases like McArdle disease.
• Regulated by exercise and insulin signaling [3, 4].
• Potential targets for anti-infective and metabolic therapies.
• Used as models to study enzyme specificity and catalysis [6, 7].
Molecular Mechanism of hexosyltransferase activity
Donor Substrate Recognition
In simple terms: The enzyme first grabs the sugar donor molecule.
Hexosyltransferases recognize specific nucleotide sugar donors, such as UDP-glucose or UDP-glucuronate, through conserved binding pockets [2, 4]. The donor substrate specificity can be determined by specific amino acid residues, as shown for Neisseria meningitidis capsule polymerases where residue 310 dictates donor preference.
Acceptor Binding and Catalysis
In simple terms: The enzyme then attaches the sugar to the target molecule.
The acceptor molecule binds to the enzyme, and the hexosyl group is transferred, forming a glycosidic bond. This step often involves a catalytic base that deprotonates the acceptor to facilitate nucleophilic attack [2, 7]. The reaction mechanism can vary depending on the enzyme family, with some utilizing a retaining or inverting mechanism.
Regulation by Phosphorylation
In simple terms: The enzyme's activity can be turned on or off by adding phosphate groups.
Many hexosyltransferases, such as glycogen synthase, are regulated by phosphorylation. Insulin and exercise modulate the phosphorylation state of glycogen synthase, affecting its activity and thus glycogen synthesis [3, 4]. This regulation ensures that glycogen storage matches energy demands.
Allosteric and Covalent Regulation
In simple terms: Other molecules can bind to the enzyme to change its shape and activity.
Allosteric effectors like glucose-6-phosphate activate glycogen synthase, while covalent modifications such as phosphorylation inhibit it. Additionally, the membrane β-hexosyltransferase from Pichia pastoris has an N-terminal region that influences its secretion and activity.
Key Genes Involved in GO:0016758 hexosyltransferase activity
Key genes encoding hexosyltransferases include those involved in glycogen metabolism, drug conjugation, and bacterial capsule synthesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GYS1 | Glycogen synthase in muscle | Regulated by exercise and insulin; mutations cause glycogen storage disorders [4, 5] |
| GYS2 | Glycogen synthase in liver | Regulates blood glucose; target for diabetes research |
| UGT1A1 | UDP-glucuronyltransferase | Drug metabolism; mutations cause Gilbert syndrome |
| UGT2B7 | UDP-glucuronyltransferase | Metabolizes opioids and NSAIDs |
| B4GALT1 | Beta-1,4-galactosyltransferase | Protein glycosylation; cancer biomarker |
| CSG2 | Capsule polymerase in Neisseria | Donor specificity; vaccine target |
| SI | Sucrase-isomaltase | Intestinal digestion; congenital sucrase-isomaltase deficiency |
| MGAM | Maltase-glucoamylase | Starch digestion; target for diabetes |
| PYGM | Glycogen phosphorylase | McArdle disease; exercise intolerance |
| PPP1R3A | Protein phosphatase 1 regulatory subunit | Regulates glycogen synthase |
| GSK3A | Glycogen synthase kinase-3 alpha | Phosphorylates and inhibits glycogen synthase |
| GSK3B | Glycogen synthase kinase-3 beta | Insulin signaling; drug target |
| INSR | Insulin receptor | Activates glycogen synthesis |
| AKT1 | Protein kinase B | Mediates insulin signaling to glycogen synthase |
| PRKAA1 | AMP-activated protein kinase | Regulates energy metabolism; activates glycogen synthesis |
| PPP1CA | Protein phosphatase 1 catalytic subunit | Dephosphorylates glycogen synthase |
| HK2 | Hexokinase 2 | Phosphorylates glucose; upstream of glycogen synthesis |
How Is hexosyltransferase activity Regulated?
Hexosyltransferase activity is regulated at multiple levels. Glycogen synthase is inhibited by phosphorylation via kinases such as GSK3 and activated by dephosphorylation by protein phosphatase 1. Insulin signaling through AKT leads to inhibition of GSK3, thereby promoting glycogen synthesis. Exercise increases AMPK activity, which can also modulate glycogen synthase. Additionally, allosteric effectors like glucose-6-phosphate provide fine-tuned control.
hexosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GYS1 | McArdle disease, glycogen storage | Knockout mouse, patient-derived iPSCs |
| UGT1A1 | Gilbert syndrome, hyperbilirubinemia | Knock-in mouse, hepatocyte cell lines |
| PYGM | McArdle disease | Knockout mouse, muscle biopsies |
| CSG2 | Meningococcal infection | Bacterial knockout, capsule synthesis assays |
| B4GALT1 | Cancer, glycosylation defects | Overexpression in cancer cell lines |
Glycogen Storage Diseases
Mutations in genes encoding glycogen synthase (GYS1, GYS2) or glycogen phosphorylase (PYGM) cause glycogen storage disorders such as McArdle disease, characterized by exercise intolerance and muscle cramps. These mutations impair hexosyltransferase activity, leading to abnormal glycogen accumulation or depletion.
Drug Metabolism Disorders
Deficiencies in UDP-glucuronyltransferases (UGTs) result in impaired glucuronidation of drugs and endogenous compounds. For example, UGT1A1 mutations cause Gilbert syndrome, characterized by mild hyperbilirubinemia. This highlights the importance of hexosyltransferase activity in detoxification.
Infectious Diseases
Bacterial capsule polymerases, such as those from Neisseria meningitidis, are hexosyltransferases that synthesize capsular polysaccharides, a major virulence factor. Understanding their donor specificity can inform vaccine design.
From hexosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GYS1 affect glycogen storage? | GYS1 knockout mouse or cell line |
| How does UGT1A1 mutation affect drug metabolism? | UGT1A1 knock-in mouse or humanized liver models |
| What is the role of CSG2 in capsule synthesis? | Neisseria meningitidis knockout |
| Can overexpression of B4GALT1 promote tumor growth? | B4GALT1 overexpression in cancer cells |
| How does exercise regulate glycogen synthase? | Exercise-trained rodent models |
| What is the effect of GSK3 inhibition on glycogen synthesis? | GSK3 knockout or inhibitor-treated cells |
How to Study the hexosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled donor assay | Enzyme activity | Glycogen synthase activity |
| Western blot | Protein phosphorylation | Regulation by insulin/exercise |
| CRISPR knockout | Loss of function | Gene function studies |
| Knock-in mutagenesis | Specific mutations | Disease modeling |
| X-ray crystallography | 3D structure | Donor specificity |
| Fluorescent substrate assay | UGT activity | Drug metabolism |
| qPCR | Gene expression | Regulation studies |
| Mass spectrometry | Glycan structure | Glycosylation analysis |
Enzymatic Activity Assays
Hexosyltransferase activity can be measured using radiolabeled donor substrates or fluorescent probes. For glycogen synthase, incorporation of UDP-[14C]glucose into glycogen is a standard assay. For UGTs, glucuronidation of substrates like bilirubin or 4-methylumbelliferone is monitored.
Genetic Knockout and Knock-in Models
CRISPR-Cas9 can generate knockout cell lines or animal models to study loss of function. Knock-in of disease-associated mutations (e.g., GYS1 or UGT1A1) allows investigation of specific variants.
Phosphorylation and Signaling Analysis
Western blotting with phospho-specific antibodies can assess the phosphorylation state of glycogen synthase and upstream kinases like AKT and GSK3 [3, 4].
Structural and Biophysical Studies
X-ray crystallography and mutagenesis can reveal donor and acceptor binding sites. For example, residue 310 in Neisseria capsule polymerases was identified as critical for donor specificity.
How CRISPR Can Be Used to Study GO:0016758 hexosyltransferase activity
Knockout
CRISPR knockout of hexosyltransferase genes (e.g., GYS1, UGT1A1) enables the study of loss-of-function phenotypes, such as impaired glycogen synthesis or drug metabolism.
Point Mutation
Introducing specific point mutations (e.g., in GYS1 or CSG2) via CRISPR base editing or HDR can model disease-associated variants and dissect catalytic residues [5, 6].
Knock-in
Knock-in of reporter tags or human orthologs allows tracking of enzyme localization and function in vivo.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate hexosyltransferase levels to study gain-of-function effects, such as enhanced glycosylation in cancer.
How EDITGENE Supports hexosyltransferase activity Research
Researchers studying hexosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease pathway. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for hexosyltransferase activity research.
Frequently Asked Questions About hexosyltransferase activity
What is hexosyltransferase activity?
Hexosyltransferase activity (GO:0016758) is the catalysis of the transfer of a hexosyl group from a donor to an acceptor molecule, as defined by the Gene Ontology.
What genes are involved in hexosyltransferase activity?
Key genes include GYS1, GYS2, UGT1A1, UGT2B7, B4GALT1, and CSG2, among others [2, 4, 6, 7].
How is hexosyltransferase activity regulated?
It is regulated by phosphorylation, allosteric effectors, and signaling pathways such as insulin and AMPK [3, 4].
What diseases are associated with hexosyltransferase mutations?
Mutations can cause glycogen storage diseases like McArdle disease, Gilbert syndrome, and affect drug metabolism [2, 5].
What methods are used to study hexosyltransferase activity?
Common methods include enzymatic assays, Western blotting, CRISPR knockout/knock-in, and structural biology [2, 4, 6].
Can CRISPR be used to model hexosyltransferase-related diseases?
Yes, CRISPR knockout and knock-in models are widely used to study gene function and disease mechanisms.
What is the role of glycogen synthase in exercise?
Glycogen synthase activity is regulated by exercise and insulin to control glycogen synthesis in muscle [3, 4].
How does UGT1A1 deficiency cause Gilbert syndrome?
UGT1A1 mutations reduce glucuronidation of bilirubin, leading to mild hyperbilirubinemia.
What is the donor substrate specificity of Neisseria capsule polymerases?
Residue 310 determines donor substrate specificity in serogroup W-135 and Y capsule polymerases.
What services does EDITGENE offer for hexosyltransferase research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
Hexosyltransferase activity (GO:0016758) is a vital molecular function with broad implications in metabolism, detoxification, and infectious disease. Understanding its regulation and genetic basis can reveal therapeutic targets and biomarkers. EDITGENE's CRISPR services empower researchers to dissect these pathways with precision.
References
- 2. Dutton GJ. 1975. Commentary: Control of UDP-glucuronyltransferase activity.. Biochem Pharmacol 24(20):1835-41 PMID: 811230
- 3. Wojtaszewski JF et al.. 2003. Insulin signalling: effects of prior exercise.. Acta Physiol Scand 178(4):321-8 PMID: 12864736
- 4. Nielsen JN et al.. 2004. Regulation of glycogen synthase activity and phosphorylation by exercise.. Proc Nutr Soc 63(2):233-7 PMID: 15294036
- 5. Nogales-Gadea G et al.. 2016. Genes and exercise intolerance: insights from McArdle disease.. Physiol Genomics 48(2):93-100 PMID: 26465709
- 6. Claus H et al.. 2009. Amino acid 310 determines the donor substrate specificity of serogroup W-135 and Y capsule polymerases of Neisseria meningitidis.. Mol Microbiol 71(4):960-71 PMID: 19170877
- 7. Dagher SF et al.. 2016. A novel N-terminal region of the membrane β-hexosyltransferase: its role in secretion of soluble protein by Pichia pastoris.. Microbiology (Reading) 162(1):23-34 PMID: 26552922
